Thibaut Mongon — EVP and Worldwide Chair of Consumer Health at Johnson & Johnson since 2019 — will be CEO of the business when it spins out as a stand-alone company.
J&J (NYSE: JNJ) expects the spinoff to be complete in 2023, subject to legal requirements, including consultation with works councils and employee representatives.
“Thibaut is a visionary and respected global leader, whose consumer-centric mindset has repeatedly propelled the business forward. Under his leadership, the Consumer Health business of Johnson & Johnson has advanced its innovation to reach consumers with products that truly make a difference in their personal health, while simultaneously delivering healthy financial results,” Executive Chair Alex Gorsky said in a news release.